Yahoo
Shanghai - Delayed Quote CNY

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)

22.67 +1.14 (+5.29%)
At close: 3:00:00 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
717,799.81
662,515.55
199,781.62
127,835.53
27,728.18
Cost of Revenue
133,797.96
64,463.67
28,951.67
1,369.84
70.64
Gross Profit
584,001.85
598,051.88
170,829.95
126,465.70
27,657.54
Operating Expense
1,480,892.16
1,449,285.08
1,166,107.72
1,196,622.20
1,019,055.83
Operating Income
-896,890.31
-851,233.19
-995,277.76
-1,070,156.50
-991,398.29
Net Non Operating Interest Income Expense
-127,869.09
-83,512.73
-37,008.49
33,417.12
34,601.68
Pretax Income
-1,056,199.77
-956,393.71
-1,047,471.48
-1,055,287.60
-958,125.80
Tax Provision
-665.76
15,864.07
-906.77
3,523.76
--
Net Income Common Stockholders
-1,050,093.27
-969,333.66
-1,043,919.22
-1,053,432.68
-955,234.57
Basic EPS
-2.53
-2.43
-2.61
-2.64
-2.44
Diluted EPS
-2.53
-2.43
-2.61
-2.64
-2.44
Basic Average Shares
418,081.93
398,902.74
399,969.05
399,027.53
391,489.58
Diluted Average Shares
418,081.93
398,902.74
399,969.05
399,027.53
391,489.58
Total Operating Income as Reported
-1,045,998.47
-955,317.72
-1,043,479.69
-1,052,579.07
-958,139.31
Total Expenses
1,614,690.12
1,513,748.75
1,195,059.38
1,197,992.03
1,019,126.47
Net Income from Continuing & Discontinued Operation
-1,050,093.27
-969,333.66
-1,043,919.22
-1,053,432.68
-955,234.57
Normalized Income
-1,043,102.25
-963,771.36
-1,036,668.07
-1,045,376.10
-953,015.65
Interest Income
10,847.26
7,609.14
20,916.96
46,884.14
45,034.08
Interest Expense
121,838.34
90,846.09
57,780.25
13,347.43
10,296.13
Net Interest Income
-127,869.09
-83,512.73
-37,008.49
33,417.12
34,601.68
EBIT
-934,361.43
-865,547.62
-989,691.23
-1,041,940.17
-947,829.67
EBITDA
-934,361.43
-647,880.78
-844,974.01
-937,628.51
-858,537.53
Reconciled Cost of Revenue
133,797.96
64,463.67
28,951.67
1,369.84
70.64
Reconciled Depreciation
184,273.90
217,666.84
144,717.22
104,311.66
89,292.14
Net Income from Continuing Operation Net Minority Interest
-1,050,093.27
-969,333.66
-1,043,919.22
-1,053,432.68
-955,234.57
Total Unusual Items Excluding Goodwill
-6,995.43
-7,416.41
-7,257.43
-10,742.10
-2,218.92
Total Unusual Items
-6,995.43
-7,416.41
-7,257.43
-10,742.10
-2,218.92
Normalized EBITDA
-927,366.01
-640,464.37
-837,716.58
-926,886.41
-856,318.61
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-4.41
-1,854.10
-6.28
-2,685.53
0
12/31/2022 - 1/18/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: